30‐Minute infusion of isatuximab in patients with newly diagnosed multiple myeloma: Results of a Phase 1b study analysis
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-11-01
|
| Series: | HemaSphere |
| Online Access: | https://doi.org/10.1002/hem3.70041 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850160967931920384 |
|---|---|
| author | Enrique M. Ocio Aurore Perrot Philippe Moreau Maria‐Victoria Mateos Sara Bringhen Joaquín Martínez‐López Lionel Karlin Song‐Yau Wang Corina Oprea Yi Li Ercem Kodas Jesus San‐Miguel |
| author_facet | Enrique M. Ocio Aurore Perrot Philippe Moreau Maria‐Victoria Mateos Sara Bringhen Joaquín Martínez‐López Lionel Karlin Song‐Yau Wang Corina Oprea Yi Li Ercem Kodas Jesus San‐Miguel |
| author_sort | Enrique M. Ocio |
| collection | DOAJ |
| format | Article |
| id | doaj-art-6f512f0c1c04412f938e07f19b14f6ba |
| institution | OA Journals |
| issn | 2572-9241 |
| language | English |
| publishDate | 2024-11-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj-art-6f512f0c1c04412f938e07f19b14f6ba2025-08-20T02:23:00ZengWileyHemaSphere2572-92412024-11-01811n/an/a10.1002/hem3.7004130‐Minute infusion of isatuximab in patients with newly diagnosed multiple myeloma: Results of a Phase 1b study analysisEnrique M. Ocio0Aurore Perrot1Philippe Moreau2Maria‐Victoria Mateos3Sara Bringhen4Joaquín Martínez‐López5Lionel Karlin6Song‐Yau Wang7Corina Oprea8Yi Li9Ercem Kodas10Jesus San‐Miguel11Servicio de Hematología y Hemoterapia, Hospital Universitario Marqués de Valdecilla University Hospital (IDIVAL) Universidad de Cantabria Santander SpainService d'Hématologie, CHU de Toulouse, IUCT‐O Université de Toulouse Toulouse FranceDepartment of Hematology University of Nantes Nantes FranceDepartment of Hematology University Hospital of Salamanca and Cancer Research Center (IBMCC‐CSICUSAL) Salamanca SpainDepartment of Onco‐Ematologia e Myeloma Multiplo, SSD Clinical Trials AOU Città della Salute e della Scienza di Torino ItalyDepartment of Hematology Hospital Universitario 12 de Octubre, CNIO, Universidad, Complutense de Madrid SpainService d'Hématologie Clinique, Hôpital Lyon Sud Hospices Civils de Lyon Pierre‐Bénite FranceDepartment of Hematology and Oncology University of Leipzig Leipzig GermanyResearch and Development, Sanofi Vitry‐sur‐Seine FranceResearch and Development, Sanofi Bejing ChinaResearch and Development, Sanofi Vitry‐sur‐Seine FranceDepartment of Clinical and Translational Medicine University of Navarra (CCUN), Center for Applied Medical Research (CIMA), IDISNA, CIBERONC Pamplona Spainhttps://doi.org/10.1002/hem3.70041 |
| spellingShingle | Enrique M. Ocio Aurore Perrot Philippe Moreau Maria‐Victoria Mateos Sara Bringhen Joaquín Martínez‐López Lionel Karlin Song‐Yau Wang Corina Oprea Yi Li Ercem Kodas Jesus San‐Miguel 30‐Minute infusion of isatuximab in patients with newly diagnosed multiple myeloma: Results of a Phase 1b study analysis HemaSphere |
| title | 30‐Minute infusion of isatuximab in patients with newly diagnosed multiple myeloma: Results of a Phase 1b study analysis |
| title_full | 30‐Minute infusion of isatuximab in patients with newly diagnosed multiple myeloma: Results of a Phase 1b study analysis |
| title_fullStr | 30‐Minute infusion of isatuximab in patients with newly diagnosed multiple myeloma: Results of a Phase 1b study analysis |
| title_full_unstemmed | 30‐Minute infusion of isatuximab in patients with newly diagnosed multiple myeloma: Results of a Phase 1b study analysis |
| title_short | 30‐Minute infusion of isatuximab in patients with newly diagnosed multiple myeloma: Results of a Phase 1b study analysis |
| title_sort | 30 minute infusion of isatuximab in patients with newly diagnosed multiple myeloma results of a phase 1b study analysis |
| url | https://doi.org/10.1002/hem3.70041 |
| work_keys_str_mv | AT enriquemocio 30minuteinfusionofisatuximabinpatientswithnewlydiagnosedmultiplemyelomaresultsofaphase1bstudyanalysis AT auroreperrot 30minuteinfusionofisatuximabinpatientswithnewlydiagnosedmultiplemyelomaresultsofaphase1bstudyanalysis AT philippemoreau 30minuteinfusionofisatuximabinpatientswithnewlydiagnosedmultiplemyelomaresultsofaphase1bstudyanalysis AT mariavictoriamateos 30minuteinfusionofisatuximabinpatientswithnewlydiagnosedmultiplemyelomaresultsofaphase1bstudyanalysis AT sarabringhen 30minuteinfusionofisatuximabinpatientswithnewlydiagnosedmultiplemyelomaresultsofaphase1bstudyanalysis AT joaquinmartinezlopez 30minuteinfusionofisatuximabinpatientswithnewlydiagnosedmultiplemyelomaresultsofaphase1bstudyanalysis AT lionelkarlin 30minuteinfusionofisatuximabinpatientswithnewlydiagnosedmultiplemyelomaresultsofaphase1bstudyanalysis AT songyauwang 30minuteinfusionofisatuximabinpatientswithnewlydiagnosedmultiplemyelomaresultsofaphase1bstudyanalysis AT corinaoprea 30minuteinfusionofisatuximabinpatientswithnewlydiagnosedmultiplemyelomaresultsofaphase1bstudyanalysis AT yili 30minuteinfusionofisatuximabinpatientswithnewlydiagnosedmultiplemyelomaresultsofaphase1bstudyanalysis AT ercemkodas 30minuteinfusionofisatuximabinpatientswithnewlydiagnosedmultiplemyelomaresultsofaphase1bstudyanalysis AT jesussanmiguel 30minuteinfusionofisatuximabinpatientswithnewlydiagnosedmultiplemyelomaresultsofaphase1bstudyanalysis |